Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?

類似資料

• Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
  著者:: Shaheer Khan, 等
  出版事項: (2022-09-01)
• Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
  著者:: Pasquale Linciano, 等
  出版事項: (2021-01-01)
• Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant <it>BRAF</it> and wildtype <it>PTEN</it> status
  著者:: Byron Sara A, 等
  出版事項: (2012-10-01)
• Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma
  著者:: Emily J. Lelliott, 等
  出版事項: (2021-05-01)
• Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat
  著者:: Tamara Zenz, 等
  出版事項: (2025-02-01)